Introducing GPT-Rosalind, our frontier reasoning model built to...
OpenAI@OpenAI
40 views
Apr 21, 2026
~1 min read
Advertisement
1
Introducing GPT-Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine.
2
On average, it takes roughly 10 to 15 years to go from target discovery to regulatory approval for a new drug in the United States.
Advanced AI systems can help researchers move faster — not just by making existing work more efficient, but by helping scientists explore more possibilities, surface connections that might otherwise be missed, and arrive at better hypotheses sooner.
Advanced AI systems can help researchers move faster — not just by making existing work more efficient, but by helping scientists explore more possibilities, surface connections that might otherwise be missed, and arrive at better hypotheses sooner.
3
GPT-Rosalind, our Life Sciences model series, is optimized for scientific workflows, with stronger performance in protein and chemical reasoning, genomics analysis, biochemistry knowledge, and scientific tool use.
4
Our Life Sciences model series is available as a research preview starting today for qualified customers including @Amgen, @moderna_tx, the @AllenInstitute, and @thermofisher Scientific through ChatGPT, Codex, and the API.
openai.com/index/introduc…
openai.com/index/introduc…